title: Rhabdomyolysis associated with cerivastatin plus gemfibrozil combined regimen.
authors.forename: Mireia
authors.initials: M
authors.lastname: Marsà Carretero
authors.forename: Cristina
authors.initials: C
authors.lastname: Alos Manrique
authors.forename: Joan-Antoni
authors.initials: JA
authors.lastname: Valles Callol
mesh_terms: D004359:Drug Therapy, Combination; D015248:Gemfibrozil / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011725:Pyridines; C086276:cerivastatin; D015248:Gemfibrozil